If all of its National Institutes of Health funding falls away, the country could lose 70% of its medical research capacity
A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while
In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support
The US has said who qualifies for a waiver during the Trump administration’s pause in foreign aid but it doesn’t allow for anti-HIV pills, unless for pregnant women
Lenacapavir drug can be made for as little as R740 per year for each patient
CAB-LA virtually eliminates someone’s chances of contracting HIV, but costs about four times more than the government can afford to pay